Open access · CC-BY
via OpenAlex
Biological age acceleration in Alzheimer’s disease modulates relative cortical to medial temporal lobe neurodegeneration
Lasya P Sreepada, Christopher A. Brown, Sandhitsu R. Das, Paul A. Yushkevich, David A. Wolk, Corey T. McMillan
Neurobiology of Aging · 2025 · ▲ 3 citations
Abstract
Alzheimer's disease (AD) is highly associated with aging, typically presenting with amnestic, multi-domain cognitive impairment and greater medial temporal lobe (MTL) atrophy relative to cortex. However, approximately 15 % of AD cases present atypically, often at younger ages and with greater cortical involvement relative to MTL. This association between age and AD presentation is imperfect: some younger-onset cases are typical, amnestic presentations while some older-onset cases present less typically. We hypothesize that this discordance may be partially modulated by discordance between chronological age and biological age, defined epigenetically. Participants from the Alzheimer's Disease Neuroimaging Initiative with MRI and known amyloid status were selected (n = 1011, 44.4 % female, 75.33 ± 7.28 years) and classified as amyloid-negative, cognitively unimpaired (n = 329) or amyloid-positive, symptomatic individuals with mild cognitive impairment or dementia (n = 682). Biological age was estimated in individuals with DNA methylation (n = 448) using established epigenetic clocks. Biological age gap (BAG) was calculated to categorize individuals into "accelerated" (biological age > chronological age) or "decelerated" (biological age < chronological age) groups. We define the Cortico-Medial Temporal index (CoMeT), derived from MRI, to quantify age-adjusted relative differences between cortical and MTL structures. Lower CoMeT scores indicate relatively greater cortical involvement. BAG and CoMeT were significantly correlated (Pearson R=0.13, p = 0.023). Symptomatic individuals with decelerated BAG exhibited significantly lower CoMeT scores than individuals with accelerated BAG, with a large effect size, reflecting greater cortical involvement relative to MTL (Wilcoxon p = 0.023, rank-biserial correlation=-0.98). We conclude that biological aging modulates AD presentation beyond chronological age, providing novel insights into mechanisms underlying AD heterogeneity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.neurobiolaging.2025.06.003
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Sreepada, L.P., Brown, C.A., Das, S.R., Yushkevich, P.A., Wolk, D.A., & McMillan, C.T. (2025). Biological age acceleration in Alzheimer’s disease modulates relative cortical to medial temporal lobe neurodegeneration. <em>Neurobiology of Aging</em>. https://doi.org/10.1016/j.neurobiolaging.2025.06.003
Vancouver
Sreepada LP, Brown CA, Das SR, Yushkevich PA, Wolk DA, McMillan CT. Biological age acceleration in Alzheimer’s disease modulates relative cortical to medial temporal lobe neurodegeneration. Neurobiology of Aging. 2025. doi:10.1016/j.neurobiolaging.2025.06.003.
BibTeX
@article{lasya2025Biolog,
title = {Biological age acceleration in Alzheimer’s disease modulates relative cortical to medial temporal lobe neurodegeneration},
author = {Lasya P Sreepada and Christopher A. Brown and Sandhitsu R. Das and Paul A. Yushkevich and David A. Wolk and Corey T. McMillan},
journal = {Neurobiology of Aging},
year = {2025},
doi = {10.1016/j.neurobiolaging.2025.06.003},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
GeroScience 2025
Open access · CC-BY
Unraveling the link between frailty and Alzheimer’s disease biomarkers in patients with mild cognitive impairment
Alzheimer s & Dementia 2022
Preprint · CC0
Biological Brain Age Prediction Using Machine Learning on Structural Neuroimaging Data: Multi‐Cohort Validation Against Biomarkers of Alzheimer’s Disease and Neurodegeneration
Neurology 2022
Open access · CC-BY
Association of Pace of Aging Measured by Blood-Based DNA Methylation With Age-Related Cognitive Impairment and Dementia
Scientific Reports 2026
Open access · CC-BY
Gut microbiome signatures associate with DNA methylation-based biological aging
ScholarlyCommons (University of Pennsylvania) 2025
Preprint
DECIPHERING EPIGENETIC SIGNATURES OF AGING AND NEURODEGENERATION IN ALZHEIMER’S DISEASE WITH MACHINE LEARNING
Alzheimer s & Dementia 2017
Citation only